Camden National Bank
Source: SEC Form 13F · as of Mar 2026Camden National Bank holds 17 biotech & pharma companies tracked by BioSniper, totaling $66.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$66.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 71,246 | $17.4M |
| MRKMerck & Co., Inc. | 112,507 | $13.5M |
| NVSNovartis AG | 70,211 | $10.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 20,907 | $9.3M |
| ZTSZoetis Inc. | 73,082 | $8.6M |
| ABBVAbbVie Inc. | 9,252 | $2.0M |
| LLYELI LILLY & Co | 1,225 | $1.1M |
| PMPhilip Morris International Inc | 3,308 | $547K |
| MCKMcKesson Corporation | 532 | $460K |
| CORCencora Inc. | 1,292 | $406K |
| PFEPFIZER INC | 11,965 | $336K |
| GILDGILEAD SCIENCES, INC. | 2,381 | $332K |
| ABTABBOTT LABORATORIES | 2,700 | $277K |
| DGXQuest Diagnostics Incorporated | 1,390 | $272K |
| IDXXIDEXX LABORATORIES INC /DE | 452 | $254K |
| IQVIQVIA Holdings Inc. | 1,244 | $212K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 772 | $209K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.